Anticorps Polyclonal de lapin anti-CD133
CD133 Polyclonal Antibody for ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain
Applications
WB, IHC, ELISA
Conjugaison
Non conjugué
N° de cat : 11141-1-AP
Synonymes
Galerie de données de validation
Applications publiées
| WB | See 8 publications below |
| IHC | See 1 publications below |
Informations sur le produit
11141-1-AP cible CD133 dans les applications de WB, IHC, ELISA et montre une réactivité avec des échantillons Humain
| Réactivité | Humain |
| Réactivité citée | Humain |
| Hôte / Isotype | Lapin / IgG |
| Clonalité | Polyclonal |
| Type | Anticorps |
| Immunogène | CD133 Protéine recombinante Ag1579 |
| Nom complet | prominin 1 |
| Masse moléculaire calculée | 97 kDa |
| Numéro d’acquisition GenBank | BC012089 |
| Symbole du gène | CD133 |
| Identification du gène (NCBI) | 8842 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Purification par affinité contre l'antigène |
| Tampon de stockage | PBS with 0.02% sodium azide and 50% glycerol |
| Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
CD133, also known as PROM1 (prominin-1) or AC133, belongs to the prominin family. CD133 is a transmembrane glycoprotein with an NH2-terminal extracellular domain, five transmembrane loops and a cytoplasmic tail. The expression of CD133 has been reported in hematopoietic stem cells, endothelial progenitor cells, neuronal and glial stem cells, suggesting the potential role of CD133 as a cell surface marker of adult stem cells. CD133 has also been reported as a marker of cancer stem cells in various human tumors.
Publications
| Species | Application | Title |
|---|---|---|
J Ethnopharmacol Huaier suppresses cisplatin resistance in non-small cell lung cancer by inhibiting the JNK/JUN/IL-8 signaling pathway | ||
J Cell Mol Med FKBP3 aggravates the malignant phenotype of diffuse large B-cell lymphoma by PARK7-mediated activation of Wnt/β-catenin signalling | ||
Evid Based Complement Alternat Med Inhibitory Effect and Mechanism of Ursolic Acid on Cisplatin-Induced Resistance and Stemness in Human Lung Cancer A549 Cells | ||
Am J Cancer Res MOGS promotes stemness acquisition and invasion via enhancing NOTCH1-glycosylation dependent NOTCH pathway in colorectal cancer | ||
J Nutr Biochem ZNF217-activated Notch signaling mediates sulforaphane-suppressed stem cell properties in colorectal cancer |
